Reported Consolidated quarterly numbers for Astec Lifesciences are:
Net Sales at Rs 69.37 crore in June 2024 down 51.44% from Rs. 142.85 crore in June 2023.
Story continues below Advertisement
Quarterly Net Loss at Rs. 39.72 crore in June 2024 down 384.77% from Rs. 8.19 crore in June 2023.
EBITDA stands negative at Rs. 45.33 crore in June 2024 down 1034.64% from Rs. 4.85 crore in June 2023.
Astec Life shares closed at 1,272.00 on July 29, 2024 (BSE) and has given 32.60% returns over the last 6 months and 1.50% over the last 12 months.
Story continues below Advertisement
| Astec Lifesciences | | Consolidated Quarterly Results | in Rs. Cr. |
|
| Jun'24 | Mar'24 | Jun'23 | | Net Sales/Income from operations | 69.37 | 153.75 | 142.85 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 69.37 | 153.75 | 142.85 | | EXPENDITURE | | Consumption of Raw Materials | 33.71 | 82.50 | 120.77 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | 47.88 | 22.82 | -18.16 | | Power & Fuel | -- | -- | -- | | Employees Cost | 16.23 | 14.69 | 15.38 | | Depreciation | 9.27 | 9.01 | 9.39 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 17.81 | 21.03 | 21.73 | | P/L Before Other Inc., Int., Excpt. Items & Tax | -55.52 | 3.70 | -6.25 | | Other Income | 0.92 | 2.05 | 1.71 | | P/L Before Int., Excpt. Items & Tax | -54.60 | 5.75 | -4.54 | | Interest | 7.04 | 6.67 | 6.46 | | P/L Before Exceptional Items & Tax | -61.64 | -0.93 | -11.01 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -61.64 | -0.93 | -11.01 | | Tax | -21.92 | 0.04 | -2.82 | | P/L After Tax from Ordinary Activities | -39.72 | -0.96 | -8.19 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -39.72 | -0.96 | -8.19 | | Minority Interest | -0.01 | -0.01 | -0.01 | | Share Of P/L Of Associates | -- | -- | -- | | Net P/L After M.I & Associates | -39.72 | -0.97 | -8.19 | | Equity Share Capital | 19.61 | 19.61 | 19.61 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -20.26 | -0.50 | -4.18 | | Diluted EPS | -20.26 | -0.50 | -4.18 | | EPS After Extra Ordinary | | Basic EPS | -20.26 | -0.50 | -4.18 | | Diluted EPS | -20.26 | -0.50 | -4.18 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
